Kidney disease as an independent risk factor for cardiovascular events

Journal of Renal Nutrition

Volumn 15, Issue 1, 2005, Pages 99-104

  Kumar, Jayant ^a   Shah, Sudhir V ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DIMETHYLARGININASE; HOMOCYSTEINE; LIPOPROTEIN;

ATHEROGENESIS; CARBAMOYLATION; CARDIOVASCULAR RISK; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATORY INFILTRATE; KIDNEY DISEASE; KIDNEY INJURY; LIPOPROTEIN BLOOD LEVEL; MEDICAL ASSESSMENT; MICROALBUMINURIA; OXIDATIVE STRESS; PROTEINURIA; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; STROKE;

ARGININE; CARDIOVASCULAR DISEASES; HUMANS; HYPERHOMOCYSTEINEMIA; INFLAMMATION; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIPOPROTEINS; LIPOPROTEINS, LDL; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PROTEINURIA; RENAL DIALYSIS; RISK FACTORS;

EID: 11844273809     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2004.09.032     Document Type: Conference Paper

References (35)

1. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169
2. P.W. Wilson, R.B. D'Agostino, D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
3. K.M. Anderson, P.W. Wilson, P.M. Odell An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
4. K/DOQI clinical practice guidelines for chronic kidney disease Evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S266
5. H. Miettinen, S.M. Haffner, S. Lehto Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and noninsulin-dependent diabetic subjects Stroke 27 1996 2033 2039
6. R. Pontremoli, G. Leoncini, M. Ravera Microalbuminuria, cardiovascular, and renal risk in primary hypertension J Am Soc Nephrol 13 suppl 3 2002 S169 172
7. H. Gerstein, J.F.E. Mann, Q. Yi HS Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426
8. K.H. Schmitz, D.K. Arnett, A. Bank Arterial distensibility and physical activity in the ARIC study Med Sci Sports Exerc 33 2001 2065 2071
9. J.F.E. Mann, H. Gerstein, J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of Ramipril The HOPE randomized trial Ann Intern Med 134 2001 629 636
10. J.F. Mann, H.C. Gerstein, I. Dulau-Florea Cardiovascular risk in patients with mild renal insufficiency Kidney Int Suppl 84 2003 S192 S196
11. The Hypertension Detection and Follow-up Program Cooperative Group N.B. Shulman, C.E. Ford, W.D. Hall Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program Hypertension 13 suppl 1989 93
12. L.M. Ruilope, A. Salvetti, K. Jamerson Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study J Am Soc Nephrol 12 2001 218 225
13. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 S112 119
14. Y. Liu, J. Coresh, J.A. Eustace Association between cholesterol level and mortality in dialysis patients Role of inflammation and malnutrition JAMA 291 2004 451 459
15. C. Rigatto Clinical epidemiology of cardiac disease in renal transplant recipients Semin Dial 16 2003 106 110
16. R.N. Foley, P.S. Parfrey, J.D. Harnett The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
17. G.M. Chertow Slowing the progression of vascular calcification in hemodialysis J Am Soc Nephrol 14 2003 S310 314
18. S.K. Venugopal, S. Devaraj, I. Yuhanna Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
19. S. Devaraj, D.Y. Xu, I. Jialal C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells Implications for the metabolic syndrome and atherothrombosis Circulation 107 2003 398 404
20. P. Stenvinkel, O. Heimburger, F. Paultre Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure Kidney Int 55 1999 1899 1911
21. J.Y. Yeun, R.A. Levine, V. Mantadilok C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 35 2000 469 476
22. S. Bro, F. Moeller, C.B. Andersen Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-e-deficient mice J Am Soc Nephrol 15 2004 1495 1503
23. T. Drueke, V. Witko-Sarsat, Z. Massy Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease Circulation 106 2002 2212 2217
24. B. Descamps-Latscha, V. Witko-Sarsat Oxidative stress in chronic renal failure and hemodialysis Nephrologie 24 2003 377 379
25. P. Vallance, A. Leone, A. Calver Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
26. L.M. Kraus, A.P.J. Kraus The search for the uremic toxin The case for carbamoylation of amino acids and proteins Wien Klin Wochenschr 110 1998 521 530
27. L.M. Kraus, A.P. Kraus Carbamylation of amino acids and proteins in uremia Kidney Int 59 2001 S102 S107
28. E. Ok, A.G. Basnakian, S.V. Shah Increased expression of adhesion molecules induced by carbamylated LDL J Am Soc Nephrol 13 2002 340A (abstr)
29. J.W. Eikelboom, G.J. Hankey Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease Curr Opin Nephrol Hypertens 10 2001 377 383
30. E.M. Wrone, J.M. Hornberger, J.L. Zehnder Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease J Am Soc Nephrol 15 2004 420 426
31. Y. Leskinen, T. Lehtimaki, A. Loimaala Homocysteine and carotid atherosclerosis in chronic renal failure--The confounding effect of renal function Atherosclerosis 175 2004 315 323
32. P. Muntner, L.L. Hamm, J.W. Kusek The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
33. C. Wanner, V. Krane, T. Metzger Lipid changes and statins in chronic renal insufficiency and dialysis J Nephrol 14 suppl 4 2001 S76 80
34. M. Boaz, S. Smetana, T. Weinstein Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE) Randomised placebo-controlled trial Lancet 356 2000 1213 1218
35. M. Tepel, M. van der Giet, M. Statz The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure A randomized, controlled trial Circulation 107 2003 992 995